Administration Method of Adjuvant Tegafur‐Uracil and Leucovorin Calcium in Patients with Resected Colorectal Cancer: A Phase III Study

LESSONS LEARNED: The 3‐year disease‐free survival rate of the twice‐daily regimen was not inferior to that of the conventional three‐times‐daily regimen, and the twice‐daily regimen did not lead to an increase in adverse events. The effectiveness of the twice‐daily regimen highlights an increased nu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hata, Taishi, Hagihara, Kiyotaka, Tsutsui, Anna, Akamatsu, Hiroki, Ohue, Masayuki, Shingai, Tatsushi, Tei, Mitsuyoshi, Ikenaga, Masakazu, Kim, Ho Min, Osawa, Hideki, Takemoto, Hiroyoshi, Konishi, Ken, Uemura, Mamoru, Matsuda, Chu, Mizushima, Tsunekazu, Murata, Kohei, Ohno, Yuko, Doki, Yuichiro, Eguchi, Hidetoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100551/
https://www.ncbi.nlm.nih.gov/pubmed/33604941
http://dx.doi.org/10.1002/onco.13724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100551/
https://www.ncbi.nlm.nih.gov/pubmed/33604941
http://dx.doi.org/10.1002/onco.13724

Ejemplares similares